Category: Uncategorized

Stablepharma has achieved an important milestone with the Td-StablevaX-M™, having successfully demonstrated stability of the reformulated Td vaccine for up to 10 months at +45ºC in collaboration with our strategic partner BB–NCIPD Ltd (Bul Bio). Td-StablevaX-M™ is a pre-filled disposable syringe containing dry stabilised tetanus diptheria vaccine for administration by injection following rehydration. Results demonstrate […]

Anh Go joins the company as Strategy and Operations Manager and brings a wealth of diverse and cross-sector experience from healthcare, life science and government. Prior to joining Stablepharma, Anh was part of the Healthcare and Life Sciences Consulting Practice at KPMG in the UK and Australia, where she focused on managing global patient pathway […]

Stablepharma is delighted to announce another new recruit to the Science team in Madrid, Spain based at Stablepharma’s Centre of Excellence (CoE) in Qube Technology Park.  With a Bachelors degree in Chemistry from the Universidad de Los Andes – Venezuela and a Biochemistry Master’s Degree from Harvard University, Daniela Briceño Garcia has more than 15 […]

Photo; Billion Photos / Shutterstock

Stablepharma’s mission to eliminate the cold chain – Published 20 hours ago on October 11, 2021By Gordon Stribling Ozgur Tuncer, Stablepharma.Özgür Tuncer, CEO and executive director of Stablepharma The World Health Organisation (WHO) estimates that up to 50 per cent of the world’s vaccine supply is wasted each year, in large part due to flaws […]

Interview with Roumen Kofinov, MD, General Manager of BB-NCIPD Ltd (Bul Bio) & Özgür Tuncer, CEO & Executive Director Stablepharma Ltd I recently interviewed Mr Roumen Kofinov, MD, General Manager of BB-NCIPD Ltd (Bul Bio) & Özgür Tuncer, CEO & Executive Director Stablepharma Ltd. The two companies have entered into a partnership to produce the […]

UK-based biotech aims to be the first fridge-free vaccine company in the world. Stablepharma Ltd, a UK-based biotech who have a novel technology platform for fridge-free vaccines, has announced the completion of the first close of their Series A, with £2 million. Funding came from existing shareholders and new investors such as Ascension Ventures and […]

I recently interviewed Professor Alan Boyd, of Boyd Consultants, Fellow of the Academy of Medical Sciences and a member of the Stablepharma Ltd Advisory Board. We covered such topics as his work with the University of Oxford & AstraZenca on the COVID-19 programme, Boyds collaboration with Wellcome on a COVID-19 human infection study and Alan’s […]

The challenges related to keeping vaccines adequately cold in many parts of the world has highlighted the need to develop vaccines that are thermostable. In doing so, it would be possible to relieve key bottlenecks in the storage and supply of vaccines, enabling more patients access to the life-saving vaccines they require. Stablepharma has patented […]

Stablepharma has partnered with the University of Strathclyde to advance their COVID mRNA vaccine thermo-stabilisation technology following positive recent COVID mRNA stability data Bath, UK, 14 July 2021: A British breakthrough invention could form a crucial part in the urgent quest to combat Covid-19 and future virus pandemics. StablevaX™ allows vaccines to be transported and […]